CHEK1 and neoplasm: Moreover, ATR–CHK1 blockade induces the accumulation of cytosolic double-stranded DNA and micronuclei, which in turn activate the cGAS/STING pathway, leading to type I interferon responses and a pro-inflammatory tumor microenvironment.